| PASG Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PASG shares outstanding history going back to 2/28/2020:
Also see: PASG Market Cap History PASG YTD Return |
As of 5/7/2026 Passage Bio has 3.21 million PASG shares outstanding. Investors often track the PASG shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PASG share count trends over time, with 25 historical shares outstanding datapoints presented, dating back to 2/28/2020.

| PASG Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PASG shares outstanding history going back to 2/28/2020:
Also see: PASG Market Cap History PASG YTD Return |
| PASG Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
PASG Historical Shares Outstanding: +8.20% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| PASG Stock Price Chart |
| About Passage Bio Inc |
| Passage Bio, Inc. is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Its clinical product candidate, PBFT02, seeks to elevate progranulin levels to restore lysosomal function and slow disease progression across a variety of neurodegenerative diseases. PBFT02 utilizes an adeno-associated virus capsid to deliver a functional granulin gene, or GRN, encoding progranulin to the brain via intra cisterna magna administration. The lead indication for PBFT02 is frontotemporal dementia, or FTD, caused by progranulin deficiency, or FTD-GRN. We show 25 historical shares outstanding datapoints in our coverage of PASG's shares outstanding history. Understanding the changing numbers of PASG shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PASG versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PASG by allowing them to research PASG shares outstanding history as well as any other stock in our coverage universe. |
| PASG Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| PASG Share Performance |
| Shares Outstanding Peers |
| Passage Bio (PASG) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PAVM Shares Outstanding History PBH Shares Outstanding History PBLA Shares Outstanding History PBYI Shares Outstanding History PCRX Shares Outstanding History PCSA Shares Outstanding History PCVX Shares Outstanding History PDCO Shares Outstanding History PDEX Shares Outstanding History PDSB Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.